Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Genomics Market Size Worth USD 27.6 Billion by 2025 | CAGR: 9.1%: Grand View Research, Inc.
N
Nice Insight
Mar 15, 2019
PR-M03-19-NI-044-2861
Cell and Gene Therapy
Press Releases
Market Dynamics
Related Content
Nonviral Delivery
Can Nonviral Delivery Change the Economics of Gene Therapy?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-02
Oct 5, 2026
Viral Vectors
Gene Therapy Manufacturing After the Capacity Boom
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-01
Oct 1, 2026
Spray Drying
Serán Bioscience Strengthens Spray Dry Capabilities with Growth Investment From Biospring Partners
Serán Bioscience
PR-09-26-05
Sep 29, 2026
AMT Designation
AustinPx’s KinetiSol™ Technology Receives FDA Advanced Manufacturing Technology Designation
AustinPx
PR-09-26-04
Sep 23, 2026
Allogeneic CAR-T
Can Allogeneic Cell Therapy Solve the CAR-T Access Problem?
Pharma's Almanac
PAO-09-26-PA-14
Sep 18, 2026
M&A
Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies
Kincellis Advanced Therapies
PR-09-26-03
Sep 17, 2026
iPSCs
For iPSC Therapies, Manufacturing Consistency May Mean Preserving Function
Pharma's Almanac
PAO-09-26-PA-09
Sep 11, 2026
Partnership
Samsung Biologics Signs USD 262 Million Manufacturing Agreement with European Pharmaceutical Company
Samsung Biologics
PR-09-26-02
Sep 10, 2026
M&A
Samsung Biologics Publishes Prospectus for PolyPeptide Public Tender Offer
Samsung Biologics
PR-09-26-01
Sep 1, 2026
Funding
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
Samsung Biologics
PR-08-26-03
Sep 1, 2026
New Brand
QPharma Builds on a Trusted Legacy to Shape the Future of Complex Drug Delivery
QPharma
PR-08-26-04
Aug 31, 2026
Potency Assurance
Why Potency Cannot Be Reduced to a Release Assay in Active Immunotherapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-16
Aug 24, 2026
Previous slide
Next slide
